Drug Type Small molecule drug |
Synonyms PXS-5120A |
Target |
Action inhibitors |
Mechanism LOXL2 inhibitors(Lysyl oxidase homolog 2 inhibitors), LOXL3 inhibitors(lysyl oxidase like 3 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC22H25ClFN3O4S |
InChIKeyPWSRWJMEGVKWES-WPTDRQDKSA-N |
CAS Registry2125955-70-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Liver Diseases | Preclinical | Australia | 14 Nov 2019 | |
Pulmonary Fibrosis | Preclinical | Australia | 14 Nov 2019 |